Venocor solution for injection 50 ml/ml, 2 ml x 10 ampoules — Made in Ukraine — Free Delivery

Product description

Venocor is an inhibitor of free radical processes, membrane protector, exhibits antihypoxic, stress protective, nootropic, anticonvulsant and anxiolytic effects. The preparation increases the body's resistance to the effects of various damaging factors, to oxygen-dependent pathological conditions (shock, hypoxia and ischemia, cerebral circulation disorders, alcohol and antipsychotic preparations  (neuroleptics) intoxication).

Venocor improves cerebral metabolism and blood supply to the brain, improves microcirculation and rheological properties of blood, and reduces platelet aggregation. It stabilizes the membrane structures of blood cells (erythrocytes and platelets) during hemolysis. Produces a hypolipidemic effect, reduces total cholesterol and low density lipoprotein (LDL). Reduces enzymatic toxemia and endogenous intoxication in acute pancreatitis.

Indications for use

• Acute disorders of cerebral circulation;
• traumatic brain injury, the consequences of traumatic brain injury;
• encephalopathy;
• cardiopsychoneurosis;
• mild cognitive impairment of atherosclerotic genesis;
• anxiety disorders in neurotic and neurosis-like states;
• acute myocardial infarction (from the first day), as part of complex therapy;
• primary open-angle glaucoma of various stages, as part of complex therapy;
• relief of withdrawal symptoms in alcoholism with a predominance of neurosis-like and vegetative-vascular disorders;
• acute intoxication with antipsychotic preparations;
• acute purulent-inflammatory processes in the abdominal cavity (acute necrotizing pancreatitis, peritonitis), as part of complex therapy.

Contraindications

Acute hepatic or renal failure, hypersensitivity to the preparation, childhood, pregnancy, lactation.

Method of administration and dosage

Venocor is prescribed intramuscularly or intravenously (jet, drip). Doses are selected individually. When administered by infusion, the preparation should be diluted in physiological sodium chloride solution (200 ml). Treatment of adults begins with a dose of 50-100 mg 1-3 times a day, gradually increasing the dose until a therapeutic effect is obtained. Jet Venocor is injected slowly over 5-7 minutes, drip - at a rate of 40-60 drops per minute. The maximum daily dose should not exceed 800 mg.

In case of acute disorders of cerebral circulation, Venocor is prescribed to adults in complex therapy in the first 2-4 days by intravenous drip of 200-300 mg 1 time per day, then intramuscularly at 100 mg 3 times a day. The treatment period is 10-14 days.

For traumatic brain injury and the consequences of traumatic brain injury Venocor is used for 10-15 days by intravenous drip of 200-500 mg 2-4 times a day.

In case of discirculatory encephalopathy in the decompensation phase, Venocor should be administered intravenously by jet or drip at a dose of 100 mg 2-3 times a day for 14 days. Then the preparation is injected intramuscularly at 100 mg per day for 2 weeks.

For the course prevention of discirculatory encephalopathy, the preparation is administered intramuscularly at 100 mg 2 times a day for 10-14 days.

For mild cognitive impairments in elderly patients and in anxiety conditions, the preparation is used intramuscularly at a dose of 100-300 mg per day for 14-30 days.

In acute myocardial infarction, Venocor is administered intravenously or intramuscularly for 14 days against the background of traditional therapy for myocardial infarction, which includes nitrates, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, thrombolytics, anti-coagulant and antiplatelet agents, as well as symptomatic agents according to indications.

In the first 5 days, in order to achieve the maximum effect, intravenous administration of Venocor is desirable, in the next 9 days, intramuscular administration of Venocor is possible. Intravenous administration of Venokor is carried out by drop infusion, slowly (to avoid side effects), with 0.9% sodium chloride solution or 5% dextrose (glucose) solution in a volume of 100-150 ml for 30-90 minutes. If necessary, a slow jet injection of Venokor is possible for at least 5 minutes.

The introduction of Venokor (intravenously or intramuscularly) is carried out 3 times a day, every 8 hours. The daily therapeutic dose is 6-9 mg per kilogram of body weight per day, a single dose is 2-3 mg / kg of body weight. The maximum daily dose should not exceed 800 mg, single dose - 250 mg.

In case of open-angle glaucoma of different stages, Venocor is used as part of complex therapy intramuscularly at 100-300 mg per day, 1-3 times a day for 14 days.

In case of alcohol withdrawal syndrome, Venocor is administered in a dose of 100-200 mg intramuscularly 2-3 times a day or intravenously drip 1-2 times a day for 5-7 days.

In case of acute intoxication with antipsychotic preparations, the preparation is administered intravenously at a dose of 50-300 mg per day for 7-14 days.

In acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis), the preparation is prescribed on the first day both in the preoperative and postoperative periods. Doses depend on the form and severity of the disease, the prevalence of the process, and the clinical course. Cancellation of the preparation should be carried out gradually, only after a stable positive clinical and laboratory effect. In acute edematous (interstitial) pancreatitis, Venocor is prescribed 100 mg 3 times a day intravenously (with isotonic sodium chloride solution) and intramuscularly. Moderate severity: adults - 200 mg 3 times a day intravenously (with isotonic sodium chloride solution). Severe course: in a pulse dosage of 800 mg on the first day with two administrations; then - 300 mg 2 times a day with a gradual decrease in the daily dose. Very severe course: at an initial dose of 800 mg per day until persistent relief of the manifestation of pancreatogenic shock, after stabilization of the state - 300-400 mg twice a day intravenously (with isotonic sodium chloride solution) with a gradual decrease in the daily dose.

Overdose

In case of an overdose, drowsiness is possible. Treatment is detoxification therapy.

Special instructions

Use during pregnancy or lactation

Strictly controlled clinical studies of the safety of the preparation during pregnancy and lactation have not been conducted, therefore Venocor is not used during this period.

Children

There have been no strictly controlled clinical studies of the safety of the preparation in children, therefore Venocor is not used in this category of patients.

The ability to influence the reaction rate when driving or driving other mechanisms

During the period of treatment, care must be taken when driving vehicles or working with mechanisms, given the likelihood of side effects that can affect the reaction rate and the ability to concentrate.

Compound

active substance: ethylmethylhydroxypyridine succinate;

1 ml of solution contains 50 mg of ethylmethylhydroxypyridine succinate;

excipients: sodium metabisulfite (E 223), water for injection.

Storage conditions

Store in original packaging at a temperature not exceeding 25 ○ С. Keep out of the reach of children.

Shelf life is 2 years.